APA (7th ed.) Citation

Calvo-Garcia, A., Ramírez Herráiz, E., Llorente Cubas, I. M., Varas De Dios, B., Benedí González, J., Morell Baladrón, A., & García-Vicuña, R. (2024). The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study. Journal of Clinical Medicine, 13(9), 2517. https://doi.org/10.3390/jcm13092517

Chicago Style (17th ed.) Citation

Calvo-Garcia, Alberto, Esther Ramírez Herráiz, Irene María Llorente Cubas, Blanca Varas De Dios, Juana Benedí González, Alberto Morell Baladrón, and Rosario García-Vicuña. "The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study." Journal of Clinical Medicine 13, no. 9 (2024): 2517. https://doi.org/10.3390/jcm13092517.

MLA (9th ed.) Citation

Calvo-Garcia, Alberto, et al. "The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study." Journal of Clinical Medicine, vol. 13, no. 9, 2024, p. 2517, https://doi.org/10.3390/jcm13092517.